noscript

News and Announcements

PrIME’s Competitive Advantage

  • Published September 06, 2012 2:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

PrIME technology is a disruptive platform technology that can be applied to the separation of any charged body that exists in liquid form and is superior to pressure-based separation technologies currently in commercial use.

PrIME Biologics’ entry into the Asian plasma products market is not in competition with existing manufacturers. Instead, PrIME is creating a new lower price point market segment in the Asian market by using Currently Unprocessable Plasma (CUP), which is currently discarded.

——-

To view the full article, please click the link below.

 

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now